Akebia Therapeutics Inc (AKBA) Stock: A Closer Look at the Analyst Ratings
Additionally, the 36-month beta value for AKBA is 0.84. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 2
Additionally, the 36-month beta value for AKBA is 0.84. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 2
The stock price of K Wave Media Ltd (NASDAQ: KWM) has jumped by 701314 compared to previous close of 4.16. Despite this, the company has
In the past week, OGN stock has gone down by -2.39%, with a monthly gain of 16.25% and a quarterly plunge of -36.32%. The volatility
Best Buy Co. Inc (NYSE: BBY) has a price-to-earnings ratio that is above its average at 16.22x. The stock has a 36-month beta value of
The stock price of AbCellera Biologics Inc (NASDAQ: ABCL) has surged by 5306582 when compared to previous closing price of 3.41, but the company has
The stock of Sphere 3D Corp (ANY) has seen a -22.52% decrease in the past week, with a -41.32% drop in the past month, and
The price-to-earnings ratio for Carrier Global Corp (NYSE: CARR) is above average at 16.47x. The 36-month beta value for CARR is also noteworthy at 1.33.
Pan American Silver Corp (NYSE: PAAS) has experienced a rise in its stock price by 3979396 compared to its previous closing price of 28.67. However,
The stock of Mirion Technologies Inc (MIR) has gone up by 2.26% for the week, with a 12.80% rise in the past month and a
Company’s 36-month beta value is 1.75.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 4 as
© 2024, Powered by Smart TechOne